Clinica San Pablo

Lima Lima-33

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Atrial Fibrillation, Idiopathic Pulmonary Fibrosis, Stroke

Studies at this site

• Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• GLORIA-AF Registry Program - Second and Third Phases — Completed
• A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication — Completed